Biofidelity

📍 Cambridge, United Kingdom🗓 Founded 2019👥 75 employees💰 Last funded Jun 2024
At Biofidelity, we’re working toward a future where more people around the world have access to the life-changing power of genomics. Our novel molecular technologies simplify genomic analysis, so more patients have access to the information needed to ensure the best possible outcomes. Our vision doesn’t end with oncology, though. Our revolutionary technologies will pave the way for tomorrow’s yet-unknown scientific breakthroughs. We believe in the transformational power of genomics. We believe that with imagination and ingenuity, anything is possible. Most importantly, when it comes to humanity’s most complex problems, we believe in the power of simple.
4
Total investors
3
Early stage
1
Mid stage
0
Late stage
2019
Founded
Investor geography2 countries
United Kingdom
3
Germany
1
Investor activity2018–2024 · investors recorded per year
201812021220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Biofidelity?
Biofidelity has 4 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage.
When did Biofidelity last raise funding?
The most recent investment in Biofidelity recorded on gritt.io was in June 2024.
When was Biofidelity founded?
Biofidelity was founded in 2019.
What industry is Biofidelity in?
Biofidelity operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Biofidelity based?
Biofidelity is headquartered in Cambridge, United Kingdom.